Bayer, the German pharmaceuticals and chemicals giant, is eyeing possible acquisitions in the area of drugs, but sees no such opportunities in its other divisions, Werner Wenning said in a newspaper interview Tuesday.
Bayer mulls major acquisitions in over the counter drugs.